<SEC-DOCUMENT>0001104659-23-072288.txt : 20230616
<SEC-HEADER>0001104659-23-072288.hdr.sgml : 20230616
<ACCEPTANCE-DATETIME>20230616163229
ACCESSION NUMBER:		0001104659-23-072288
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		13
CONFORMED PERIOD OF REPORT:	20230613
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230616
DATE AS OF CHANGE:		20230616

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Apollo Medical Holdings, Inc.
		CENTRAL INDEX KEY:			0001083446
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		IRS NUMBER:				870042699
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-37392
		FILM NUMBER:		231021722

	BUSINESS ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801
		BUSINESS PHONE:		(626) 282-0288

	MAIL ADDRESS:	
		STREET 1:		1668 S. GARFIELD AVENUE
		STREET 2:		2ND FLOOR
		CITY:			ALHAMBRA
		STATE:			CA
		ZIP:			91801

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SICLONE INDUSTRIES INC
		DATE OF NAME CHANGE:	19990413
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tm2318926d1_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:us-roles="http://fasb.org/us-roles/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:AMEH="http://apollomed.net/20230613">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02A_US%2DGAAP%2D2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_03C_AMEH_apollomed.net_20230613 -->
<!-- Field: Set; Name: xdx; ID: xdx_044_20230613_20230613 -->
<!-- Field: Set; Name: xdx; ID: xdx_053_edei%2D%2DEntityCentralIndexKey_0001083446 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2023-06-13to2023-06-13" name="dei:EntityCentralIndexKey">0001083446</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2023-06-13to2023-06-13" name="dei:AmendmentFlag">false</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="ameh-20230613.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2023-06-13to2023-06-13">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001083446</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-06-13</xbrli:startDate>
        <xbrli:endDate>2023-06-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="margin: 0">&#160;</p>

<p style="margin: 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>UNITED STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>SECURITIES AND
EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="text-transform: uppercase"><b>Washington,
DC 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-size: 10pt"><b>FORM <span id="xdx_90F_edei--DocumentType_c20230613__20230613_zYu8K5nETfjj"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Pursuant to Section&#160;13 or 15(d)
of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Securities Exchange Act of 1934</b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event reported):
June 16, 2023 (<span id="xdx_909_edei--DocumentPeriodEndDate_c20230613__20230613_zGaGW6zgsrQh"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">June 13, 2023</ix:nonNumeric></span>)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span id="xdx_90C_edei--EntityRegistrantName_c20230613__20230613_z8P8Crkbwjca"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" name="dei:EntityRegistrantName">APOLLO MEDICAL HOLDINGS, INC.</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in its
Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_906_edei--EntityIncorporationStateCountryCode_c20230613__20230613_zVwuALpSUgmb"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></span></td>
    <td style="width: 34%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_90B_edei--EntityFileNumber_c20230613__20230613_zTpKuMSMqXi6"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" name="dei:EntityFileNumber">001-37392</ix:nonNumeric></span></span></td>
    <td style="width: 33%; text-align: center"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_900_edei--EntityTaxIdentificationNumber_c20230613__20230613_z0hjZY8dfA42"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" name="dei:EntityTaxIdentificationNumber">95-4472349</ix:nonNumeric></span></span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(State or Other Jurisdiction</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Commission </span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I.R.S. Employer</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">of Incorporation)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">File Number)</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identification No.)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span id="xdx_909_edei--EntityAddressAddressLine1_c20230613__20230613_zGkBmRJAv2rb"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" name="dei:EntityAddressAddressLine1">1668 S. Garfield Avenue</ix:nonNumeric></span>, <span id="xdx_90D_edei--EntityAddressAddressLine2_c20230613__20230613_zGkqsrPajvOc"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" name="dei:EntityAddressAddressLine2">2nd Floor</ix:nonNumeric></span>, <span id="xdx_90E_edei--EntityAddressCityOrTown_c20230613__20230613_z6dXuCFx7HAi"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" name="dei:EntityAddressCityOrTown">Alhambra</ix:nonNumeric></span>, <span id="xdx_90B_edei--EntityAddressStateOrProvince_c20230613__20230613_zzlybikYcQBh"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince">California</ix:nonNumeric></span> <span id="xdx_90F_edei--EntityAddressPostalZipCode_c20230613__20230613_zWikYRyRYe4a"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" name="dei:EntityAddressPostalZipCode">91801</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address of Principal Executive Offices) (Zip Code)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(<span id="xdx_901_edei--CityAreaCode_c20230613__20230613_zRJQMB2rByf1"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" name="dei:CityAreaCode">626</ix:nonNumeric></span>) <span id="xdx_90C_edei--LocalPhoneNumber_c20230613__20230613_z9mBqRbwbPb3"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" name="dei:LocalPhoneNumber">282-0288</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s Telephone Number, Including
Area Code</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0 auto; width: 40%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Former Name or Former Address, if Changed Since
Last Report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_901_edei--WrittenCommunications_c20230613__20230613_zQk8Ix6rdTah"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" format="ixt:booleanfalse" name="dei:WrittenCommunications">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_90A_edei--SolicitingMaterial_c20230613__20230613_z5VKy6BFpW31"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" format="ixt:booleanfalse" name="dei:SolicitingMaterial">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_90C_edei--PreCommencementTenderOffer_c20230613__20230613_zxEcvWdfSe2b"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" format="ixt:booleanfalse" name="dei:PreCommencementTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="width: 0.25in">&#160;</td>
    <td style="width: 0.25in"><span style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Wingdings"><span id="xdx_900_edei--PreCommencementIssuerTenderOffer_c20230613__20230613_zZrxqoeedba7"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" format="ixt:booleanfalse" name="dei:PreCommencementIssuerTenderOffer">&#168;</ix:nonNumeric></span></span></span></td>
    <td style="text-align: justify"><span style="font: 10pt Times New Roman, Times, Serif">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Securities registered pursuant to Section 12(b) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-top: 1pt; width: 25%; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Title of each class</span></td>
    <td style="border-top: Black 1pt solid; border-left: Black 1pt solid; padding-top: 1pt; width: 25%; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Trading Symbol(s)</span></td>
    <td style="border: Black 1pt solid; padding-top: 1pt; width: 50%; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif">Name of each exchange on which registered</span></td></tr>
<tr style="vertical-align: bottom">
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 1pt; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_907_edei--Security12bTitle_c20230613__20230613_zEYyIJP0Dad4"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" name="dei:Security12bTitle">Common Stock</ix:nonNumeric></span></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 1pt; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_905_edei--TradingSymbol_c20230613__20230613_zDMXGZN6blBc"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" name="dei:TradingSymbol">AMEH</ix:nonNumeric></span></span></td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; padding-top: 1pt; text-align: center; padding-bottom: 1pt"><span style="font: 10pt Times New Roman, Times, Serif"><span id="xdx_904_edei--SecurityExchangeName_c20230613__20230613_zJmS29PZGi09"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Capital Market</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-size: 10pt">Emerging growth company&#160;</span><span style="font-family: Wingdings"><span id="xdx_90E_edei--EntityEmergingGrowthCompany_c20230613__20230613_zrALSxW6YdYf"><ix:nonNumeric contextRef="From2023-06-13to2023-06-13" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#168;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-size: 10pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160;</span><span style="font-family: Wingdings">&#168;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="width: 34%">&#160;</td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 5.02</b></td><td><b>Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
stockholders of Apollo Medical Holdings, Inc. (the &#8220;Company&#8221;) approved the Apollo Medical Holdings, Inc. Employee Stock Purchase
Plan (the &#8220;ESPP&#8221;) at the 2023 Annual Meeting of Stockholders of the Company (the &#8220;Annual Meeting&#8221;) held on June
13, 2023. The ESPP was previously approved by the Company&#8217;s Board of Directors (the &#8220;Board&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
objective of the ESPP is to offer eligible employees and consultants of the Company and its designated subsidiaries the ability to purchase
shares of the Company&#8217;s common stock at a discount, subject to various limitations under the ESPP. The Board believes that the ESPP
will promote broad-based ownership of the Company&#8217;s common stock by eligible employees and consultants and will help to align the
interests of ESPP participants with those of the Company&#8217;s stockholders. The ESPP will be administered by the Compensation Committee
of the Board (the &#8220;Administrator&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
maximum number of shares of the Company&#8217;s common stock that will be authorized for issuance under the ESPP is 5,000,000 shares,
subject to adjustment. The shares reserved for issuance under the ESPP may be authorized but unissued shares, treasury shares, or shares
from any other proper source.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;The
ESPP is divided into two components: the &#8220;423 Component&#8221; and the &#8220;Non-423 Component.&#8221; The 423 Component is intended
to qualify as an &#8220;employee stock purchase plan&#8221; under Section 423 of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;).
The Non-423 Component is not intended to qualify under Section 423 of the Code. Employees eligible to participate in the 423 Component
of the ESPP for a given offering generally include all employees who are employed by the Company or one of its designated subsidiaries
for that offering, subject to limitations that may be imposed under the ESPP consistent with Section 423 of the Code. The Administrator
will determine which employees and consultants of designated subsidiaries will be eligible to participate in the Non-423 Component of
the ESPP for a given offering. In any case, participation in the ESPP is voluntary and dependent on each eligible employee&#8217;s (or
consultant<span style="color: Black">&#8217;s) election to participate, as well as the level of payroll deductions elected by each participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="color: Black">Participants
will be granted the right to purchase shares of the Company&#8217;s common stock at a discount during a series of successive offerings.
Unless and until otherwise determined by the Administrator, each offering period will be a six-month period beginning on the first day
of a calendar quarter and ending on the last day of the next succeeding calendar quarter. However, in no event may any single offering
period be longer than 27 months. The purchase price for each offering will be established by the Administrator, provided that in no event
will the purchase price established by the Administrator for any offering be less than the lower of (i) 85% of the closing price per
share of the Company&#8217;s common stock on the first trading day of the offering period, or (ii) 85% of the closing price per share
on the exercise date, which will occur on the last trading day of each offering period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="color: Black">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white"><span style="color: Black">A
summary of the ESPP is included in&#160;<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1083446/000162828023014191/ameh-20230428.htm#i186e8c65eb614afeb595711f095c29c6_43">Proposal 4</a>&#160;of the Company&#8217;s Definitive Proxy Statement on Schedule 14A filed with
the Securities and Exchange Commission on April 28, 2023 (the &#8220;Proxy Statement&#8221;), which summary is incorporated in its
entirety herein by reference. The summaries of the ESPP contained herein and in the Proxy Statement do not purport to be complete
and are subject to, and qualified in their entirety by reference to, the full text of the ESPP, a copy of which is filed as <a href="tm2318926d1_ex10-1.htm" style="-sec-extract: exhibit">Exhibit 10.1</a> to this Current Report on Form 8-K and is incorporated herein by reference.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 5.07</b></td><td style="text-align: justify"><b>Submission of Matters to a Vote of Security Holders.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Company held its Annual Meeting on June 13, 2023. At the close of business on April 25, 2023, the record date for the Annual Meeting (the
&#8220;Record Date&#8221;), there were 57,550,326 shares of common stock, par value $0.001 per share, of the Company issued and outstanding,
each share being entitled to one vote and to be voted together as one class vote at the Annual Meeting. At the Annual Meeting, there were
present in person or by proxy 45,029,723 shares of the Company&#8217;s common stock, representing stockholders entitled to cast approximately
78.24% of the total outstanding eligible votes and constituting a quorum. As of the Record Date, 1,111,111 shares of the Company&#8217;s
Series A preferred stock and 555,555 shares of the Company&#8217;s Series B preferred stock, par value $0.001 per share, were held by
Network Medical Management, Inc., a wholly-owned subsidiary of the Company, and therefore, pursuant to the Delaware General Corporation
Law, such shares of preferred stock were not voted, nor counted for quorum purposes, at the Annual Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Set
forth below are the voting results for the four proposals considered and voted upon at the Annual Meeting, all of which were described
in the Proxy Statement filed with the Securities and Exchange Commission on April 28, 2023:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"></p>

<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Proposal 1. Election of Directors</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Company&#8217;s stockholders elected, by the votes indicated below, nine persons to serve as directors of the Company until its 2024 Annual
Meeting of Stockholders and until their successors are duly elected and qualified. The following sets forth the results of the voting
with respect to each candidate:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Director</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">For</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Withheld</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><span style="font-size: 10pt"><b>Broker Non-Votes<sup>(1)</sup></b></span></td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; font-size: 10pt; text-align: left">Kenneth Sim, M.D.</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 12%; font-size: 10pt; text-align: right">36,859,352</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 12%; font-size: 10pt; text-align: right">712,345</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 12%; font-size: 10pt; text-align: right">7,458,026</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Thomas S. Lam, M.D., M.P.H.</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">37,208,834</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">362,863</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">7,458,026</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Mitchell W. Kitayama</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">35,714,486</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,857,211</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">7,458,026</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">David G. Schmidt</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">36,312,649</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,259,048</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">7,458,026</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Linda Marsh</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">36,229,555</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,342,142</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">7,458,026</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">John Chiang</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">36,384,534</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,187,163</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">7,458,026</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Matthew Mazdyasni</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">36,003,599</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">1,568,098</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">7,458,026</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">J. Lorraine Estradas, R.N., B.S.N. M.P.H.</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">35,536,495</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">2,035,202</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">7,458,026</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Weili Dai</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">37,269,055</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">302,642</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">7,458,026</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; background-color: white">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">Broker non-votes represent proxies that are uninstructed on
a proposal and submitted by brokers or other nominees who lack discretionary authority to vote on the proposal absent instructions from
the beneficial owner of shares of stock.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Based
on these voting results, each of the nine nominees for director were elected to serve until the Company&#8217;s 2024 Annual Meeting of
Stockholders and until his or her successor has been duly elected and qualified.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Proposal 2. Ratification of Appointment
of Independent Registered Public Accounting Firm</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Company&#8217;s stockholders voted to ratify the appointment of Ernst &amp; Young LLP as the Company&#8217;s independent registered public
accounting firm for the fiscal year ending December 31, 2023. 44,877,735 votes were cast &#8220;for&#8221; the ratification, 28,371 votes
were cast &#8220;against&#8221; the ratification and 123,617 votes abstained. There were no broker non-votes for this proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Based
on these voting results, the stockholders ratified the appointment of Ernst &amp; Young LLP as the Company&#8217;s independent registered
public accounting firm for the fiscal year ending December 31, 2023.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Proposal 3. Advisory Vote on Executive
Compensation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Company&#8217;s stockholders voted, on a non-binding, advisory basis, to approve the compensation of the Company&#8217;s named executive
officers. 20,670,215 votes were cast &#8220;for&#8221; the proposal, 16,805,967 votes&#160;were cast &#8220;against&#8221; the proposal
and 95,515 votes abstained. Additionally, there were 7,458,026 broker&#160;non-votes for this proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Based
on these voting results, the stockholders approved the compensation of&#160;the Company&#8217;s named executive officers as disclosed
in the Proxy Statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><b>Proposal 4. Approval of the Apollo Medical
Holdings, Inc. Employee Stock Purchase Plan</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Company&#8217;s stockholders voted to approve the ESPP. 37,268,131 votes were cast &#8220;for&#8221; the proposal, 300,550 votes&#160;were
cast &#8220;against&#8221; the proposal and 3,016 votes abstained. Additionally, there were 7,458,026 broker non-votes for this proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">Based
on these voting results, the stockholders approved the ESPP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 1in"><b>Item 9.01</b></td><td><b>Financial Statements and Exhibits.</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">(d) Exhibits.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding: 0; text-indent: 0; width: 10%; text-align: center"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="padding: 0; text-indent: 0; width: 2%">&#160;</td>
    <td style="padding: 0; text-indent: 0; width: 88%; text-align: center"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr>
    <td style="border-top: black 1pt solid; padding: 0; text-indent: 0; vertical-align: top; text-align: center"><a href="tm2318926d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">10.1</span></a></td>
    <td style="padding: 0; text-indent: 0; vertical-align: bottom">&#160;</td>
    <td style="border-top: black 1pt solid; padding: 0; text-indent: 0; vertical-align: bottom"><a href="tm2318926d1_ex10-1.htm" style="-sec-extract: exhibit"><span style="font-size: 10pt">Apollo Medical Holdings, Inc. Employee Stock Purchase Plan.</span></a></td></tr>
  <tr>
    <td style="padding: 0; text-indent: 0; vertical-align: top; text-align: center"><span style="font-size: 10pt">104</span></td>
    <td style="padding: 0; text-indent: 0">&#160;</td>
    <td style="padding: 0; text-indent: 0; vertical-align: bottom"><span style="font-size: 10pt">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p>




<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 49.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding: 0; text-indent: 0; vertical-align: top">&#160;</td>
    <td colspan="2" style="padding: 0; text-indent: 0; vertical-align: bottom"><span style="font-size: 10pt"><b>APOLLO MEDICAL HOLDINGS, INC.</b></span></td></tr>
  <tr>
    <td style="padding: 0; text-indent: 0; vertical-align: top">&#160;</td>
    <td colspan="2" style="padding: 0; text-indent: 0; vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="padding: 0; text-indent: 0; vertical-align: top; width: 50%"><span style="font-size: 10pt">Date: June 16, 2023</span></td>
    <td style="padding: 0; text-indent: 0; vertical-align: bottom; width: 5%"><span style="font-size: 10pt">By: </span></td>
    <td style="padding: 0; text-indent: 0; vertical-align: top; width: 45%"><span style="font-size: 10pt">/s/ Thomas S. Lam</span></td></tr>
  <tr>
    <td style="padding: 0; text-indent: 0; vertical-align: top">&#160;</td>
    <td style="padding: 0; text-indent: 0; vertical-align: bottom"><span style="font-size: 10pt">Name:<br />
Title:</span></td>
    <td style="border-top: black 1pt solid; padding: 0; text-indent: 0; vertical-align: bottom"><span style="font-size: 10pt">Thomas S. Lam, M.D., M.P.H.<br />
Co-Chief Executive Officer and President</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

</body>
</html>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFTdsKgkAQ/QL/YdjnKBV88bGlIrIIkeh1yymWdEdmt9sn9ZeNSjQcmNu5KDVRK1raBhmO87KACtuuMQGhxAsyujMKQ683OUgv8Wp9YOPCsP6EmkSDosmm2UnuA/NhPdY5JMlMkMYy5FkG+62K+r8md7E1umBNA8bVsGfq2GIw/B4dKvMiR+17SDoge0tO7Kbx+P5AGicp7OhhnsQ3D0WhVTQZKlIrpnvXx9x9oBYWDbaS5UfpH9EX2qhJFA== -->
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>tm2318926d1_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="text-align: right; margin: 0"><B>Exhibit 10.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>APOLLO MEDICAL HOLDINGS, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>EMPLOYEE STOCK PURCHASE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>1.&nbsp;Establishment
and Purpose of Plan</B>. This Apollo Medical Holdings, Inc. Employee Stock Purchase Plan (the &ldquo;<U>Plan</U>&rdquo;) was adopted by
the Board effective April 21, 2023, subject to approval of the Plan by the stockholders of the Company at the 2023 Annual Meeting of Stockholders.
The purpose of the Plan is to provide to eligible service providers of the Company and its Designated Subsidiaries opportunities to purchase
shares of the Company&rsquo;s Common Stock. The Plan includes two components: a Code Section&nbsp;423 Component (the&nbsp;&ldquo;<U>423
Component</U>&rdquo;)<I>&nbsp;</I>and a&nbsp;non-Code&nbsp;Section&nbsp;423 Component (the&nbsp;&ldquo;<U>Non-423&nbsp;Component</U>&rdquo;).
It is intended for the 423 Component to constitute an &ldquo;employee stock purchase plan&rdquo; within the meaning of Section&nbsp;423(b)
of the Code, pursuant to which Purchase Rights may be granted to Eligible Employees, and the 423 Component shall be interpreted in accordance
with that intent. Under the&nbsp;Non-423&nbsp;Component, which is not intended to qualify as an &ldquo;employee stock purchase plan&rdquo;
within the meaning of Section&nbsp;423(b) of the Code, Purchase Rights may be granted to Eligible Employees and Consultants pursuant to
rules, procedures or&nbsp;sub-plans&nbsp;adopted by the Administrator and designed to achieve tax, securities laws or other objectives.
Except as otherwise provided herein, the&nbsp;Non-423&nbsp;Component shall operate and be administered in the same manner as the 423 Component.
Unless otherwise defined herein, capitalized terms used in this Plan shall have the meanings ascribed to them in&nbsp;Section&nbsp;2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>2.&nbsp;Definitions</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;&ldquo;<U>423 Component</U>&rdquo;<I>&nbsp;</I>has
the meaning set forth in Section 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;&ldquo;<U>Administrator</U>&rdquo;<I>&nbsp;</I>means
the Committee (or a delegate appointed in accordance with&nbsp;Section&nbsp;4(b)).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;&ldquo;<U>Board</U>&rdquo;&nbsp;means
the Board of Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;&ldquo;<U>Code</U>&rdquo;<I>&nbsp;</I>means
the Internal Revenue Code of 1986, as amended from time to time, or any successor thereto. A reference to any specific section of the
Code shall also be deemed to be a reference to the provisions of any section of the final treasury regulations issued by the U.S. Department
of the Treasury under the Code, as amended from time to time, under that Code section.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;&ldquo;<U>Committee</U>&rdquo;<I>&nbsp;</I>means
the Compensation Committee of the Board (or any other committee or subcommittee of the Board which the Board may appoint to administer
the Plan). Subject to the discretion of the Board, the Committee shall be composed entirely of individuals who meet the qualifications
of (i)&nbsp;a&nbsp;&ldquo;non-employee&nbsp;director&rdquo; within the meaning of Rule&nbsp;16b-3&nbsp;under the Securities Exchange Act
of 1934, as amended, and (ii)&nbsp;any other qualifications required by the applicable exchange on which the Common Stock is traded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;&ldquo;<U>Common
Stock</U>&rdquo; means the Company&rsquo;s common stock, par value $0.001 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;&ldquo;<U>Company</U>&rdquo;&nbsp;means
Apollo Medical Holdings, Inc., a Delaware corporation (or any successor corporation).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;&ldquo;<U>Compensation</U>&rdquo;<I>&nbsp;</I>means,
except as otherwise determined by the Administrator, an Eligible Employee&rsquo;s (or, with respect to the Non-423 Component, a Consultant&rsquo;s)
base pay and cash incentive bonus otherwise payable during an Offering, prior to salary reduction (such as pursuant to Sections 125, 132(f)
or 401(k) of the Code), as determined by the Administrator. The Administrator shall have the discretion to determine the application of
this definition to Participants, including those outside working outside the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&ldquo;<U>Consultant</U>&rdquo;
means an individual who performs services for the Company or a Subsidiary as an independent contractor and in a capacity other than as
an employee or a member of a board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;&ldquo;<U>Designated
Subsidiary</U>&rdquo;<I>&nbsp;</I>means any present or future Subsidiary that has been designated by the Administrator to participate
in the Plan. The Administrator may so designate any Subsidiary, or revoke any such designation, at any time and from time to time, either
before or after the Plan is approved by the stockholders, and may further designate such Designated Subsidiaries as participating in the
423 Component or the&nbsp;Non-423&nbsp;Component. The Administrator may also determine which Subsidiaries may be excluded from participation
in the Plan, to the extent consistent with Section&nbsp;423 of the Code or as implemented under the&nbsp;Non-423&nbsp;Component, and which
Designated Subsidiaries shall participate in separate Offerings. For purposes of clarity, under the 423 Component, only those Subsidiaries
that qualify as &ldquo;subsidiary corporations&rdquo; to the Company within the meaning of Section 424(f) of the Code may be Designated
Subsidiaries with respect to any Offering under the 423 Component.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&nbsp;&ldquo;<U>Eligible
Employee</U>&rdquo;<I>&nbsp;</I>has the meaning set forth in&nbsp;Section&nbsp;6.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)&nbsp;&ldquo;<U>Enrollment
Form</U>&rdquo;<I>&nbsp;</I>means an agreement, which may be electronic, pursuant to which an Eligible Employee (or, with respect to the
Non-423 Component, a Consultant) may elect to enroll in the Plan, to authorize a new level of payroll deductions, or to stop payroll deductions
and withdraw from an Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)&nbsp;&ldquo;<U>Exercise
Date</U>&rdquo;<I>&nbsp;</I>means the last Trading Day of a Purchase Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)&nbsp;&ldquo;<U>Fair
Market Value</U>&rdquo;<I>&nbsp;</I>on any given date means the closing price of the Common Stock on the applicable Trading Day, as reported
on the NASDAQ Capital Market&nbsp;or such other national securities exchange upon which the Common Stock may be listed at the time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(o)&nbsp;&ldquo;<U>Non-423&nbsp;Component</U>&rdquo;<I>&nbsp;</I>has
the meaning set forth in&nbsp;Section&nbsp;1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(p)&nbsp;&ldquo;<U>Offering</U>&rdquo;<I>&nbsp;</I>means
an offering to Eligible Employees (or, with respect to the Non-423 Component, Consultants) to purchase Common Stock under the Plan. Unless
otherwise determined by the Administrator, each Offering under the 423 Component in which Eligible Employees of one or more Designated
Subsidiaries may participate may be deemed a separate offering for purposes of Section&nbsp;423 of the Code, even if the dates of the
applicable Offering are identical, and the provisions of the Plan will separately apply to each Offering. With respect to Offerings under
the 423 Component, the terms of separate Offerings need not be identical, provided that all Eligible Employees granted a Purchase Right
in a particular Offering under the 423 Component will have the same rights and privileges, except as otherwise may be permitted by Code
Section&nbsp;423; Offerings under the&nbsp;Non-423&nbsp;Component need not satisfy such requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(q)&nbsp;&ldquo;<U>Offering
Date</U>&rdquo;<I>&nbsp;</I>means the first Trading Day of an Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(r)&nbsp;&ldquo;<U>Parent</U>&rdquo;<I>&nbsp;</I>means
a &ldquo;parent corporation&rdquo; with respect to the Company, as defined in Section&nbsp;424(e) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(s)&nbsp;&ldquo;<U>Participant</U><I>&rdquo;&nbsp;</I>means:
(i) with respect to the 423 Component, an Eligible Employee as provided in&nbsp;Section&nbsp;6&nbsp;who has enrolled in the Plan in compliance
with the provisions of&nbsp;Section&nbsp;7; and (ii) with respect to the Non-423 Component, an Eligible Employee or Consultant whom the
Administrator has determined to be eligible to participate in the Non-423 Component pursuant to Section 6 and who has enrolled in the
Plan in compliance with the provisions of&nbsp;Section&nbsp;7.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(t)&nbsp;&ldquo;<U>Plan</U>&rdquo;<I>&nbsp;</I>means
the Apollo Medical Holdings, Inc. Employee Stock Purchase Plan, as set forth in this document and as it may be amended from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(u)&nbsp;&ldquo;<U>Purchase
Period</U>&rdquo;<I>&nbsp;</I>means the period of time specified within an Offering beginning on the Offering Date and ending on the Exercise
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v)&nbsp;&ldquo;<U>Purchase
Price</U>&rdquo;<I>&nbsp;</I>has the meaning set forth in&nbsp;Section&nbsp;11.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(w)&nbsp;&ldquo;<U>Purchase
Right</U>&rdquo;<I>&nbsp;</I>has the meaning set forth in&nbsp;Section&nbsp;11.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(x)&nbsp;&ldquo;<U>Reorganization
Event</U>&rdquo;<I>&nbsp;</I>means: (i)&nbsp;the sale of all or substantially all of the assets of the Company on a consolidated basis
to an unrelated person or entity; (ii)&nbsp;a merger, reorganization or consolidation pursuant to which the holders of the Company&rsquo;s
aggregate outstanding voting power and outstanding stock immediately prior to such transaction do not own a majority of the aggregate
outstanding voting power and outstanding stock or other equity interests of the resulting or successor entity (or its ultimate parent,
if applicable) immediately upon completion of such transaction; (iii)&nbsp;the sale of all of the Common Stock to an unrelated person,
entity or group thereof acting in concert; or (iv)&nbsp;any other transaction in which the owners of the Company&rsquo;s outstanding voting
power immediately prior to such transaction do not own at least a majority of the outstanding voting power of the Company or any successor
entity immediately upon completion of the transaction other than as a result of the acquisition of securities directly from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(y)&nbsp;&ldquo;<U>SEC</U>&rdquo;&nbsp;means
the United States Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(z)&nbsp;&ldquo;<U>Subsidiary</U>&rdquo;<I>&nbsp;</I>means
(i) with respect to the 423 Component, a &ldquo;subsidiary corporation&rdquo; of the Company within the meaning Section&nbsp;424(f) of
the Code, and (ii) with respect to the Non-423 Component, any entity that, directly or indirectly through one or more intermediaries,
controls, is controlled by or is under the common control with, the Company, whether or not such entity is a &ldquo;subsidiary corporation&rdquo;
of the Company within the meaning of Section&nbsp;424(f) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(aa)&#9;&ldquo;<U>Trading Day</U>&rdquo;
means a day on which the NASDAQ Capital Market&nbsp;(or such other national securities exchange upon which the Common Stock may be listed
at the time) is open for trading.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 3; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>3.&nbsp;Share
Reserve</B>. Subject to adjustment as provided in Section&nbsp;15, the maximum aggregate number of shares of Common Stock that may be
issued under the Plan shall be 5,000,000 shares, which shall consist of authorized but unissued shares, treasury shares, shares acquired
on the open market, or any combination thereof. If an outstanding Purchase Right for any reason expires or is terminated or canceled without
the issuance of shares of Common Stock thereunder, the shares of Common Stock allocable to the unexercised portion of that Purchase Right
shall again be available for issuance under the Plan. For the avoidance of doubt, up to the maximum number of shares of Common Stock reserved
under this Section&nbsp;3 may be used to satisfy purchases of Common Stock under the 423 Component, and any remaining portion of such
maximum number of shares may be used to satisfy purchases of Common Stock under the Non-423 Component.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>4.&nbsp;Administration</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;<U>In
General</U>. The Plan shall be administered by the Administrator. The Administrator has full authority at any time to: (i)&nbsp;adopt,
alter and repeal such rules, guidelines and practices for the administration of the Plan and for its own acts and proceedings as it shall
deem advisable and appoint such agents as it deems appropriate for the proper administration of the Plan; (ii)&nbsp;interpret and construe,
reconcile any inconsistency in, correct any default in and supply any omission in, and apply the terms of the Plan and any Enrollment
Form or other instrument or agreement relating to the Plan; (iii)&nbsp;determine the terms and conditions of any right to purchase shares
of Common Stock under the Plan; (iv)&nbsp;make all determinations and take all actions it deems advisable for the administration of the
Plan, including to accommodate the specific requirements of local laws, regulations and procedures for jurisdictions outside the United
States, such as adopting rules and procedures regarding payment of interest (if any), conversion of local currency, payroll tax, withholding
procedures and handling of stock certificates that vary with local requirements outside of the United States, and adopting&nbsp;sub-plans&nbsp;applicable
to particular Designated Subsidiaries or locations, which&nbsp;sub-plans&nbsp;may be necessary or appropriate to permit the participation
in the Plan by employees who are foreign nationals or employed outside the United States, as further set forth in&nbsp;Section&nbsp;17&nbsp;below;
(v)&nbsp;determine eligibility and decide all disputes arising in connection with the Plan, including whether Eligible Employees will
participate in the 423 Component, whether Eligible Employees or Consultants will participate in the&nbsp;Non-423&nbsp;Component, and which
Subsidiaries will be Designated Subsidiaries under the 423 Component or the&nbsp;Non-423&nbsp;Component; (vi)&nbsp;amend an outstanding
right to purchase shares of Common Stock, including any amendments to a right that may be necessary for purposes of effecting a transaction
contemplated under Section 15 or Section 16 (including, but not limited to, an amendment to the class or type of stock that may be issued
pursuant to the exercise of a right or the Purchase Price applicable to a right), provided that the amended right otherwise conforms to
the terms of the Plan; and (vii)&nbsp;otherwise supervise and take any other actions necessary or desirable for the administration of
the Plan. All interpretations and decisions of the Administrator shall be binding on all persons, including the Company and the Participants.
Neither the Administrator nor any member of the Board, the Committee or any other individual exercising administrative authority with
respect to the Plan shall be liable for any action or determination made in good faith with respect to the Plan or any Purchase Right
granted hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;<U>Delegation</U>.
Subject to applicable laws, the Administrator may delegate administrative authority hereunder to one or more officers of the Company or
to such other individual or group as the Administrator may determine in its discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;<U>Authority
of the Board</U>. The Board may reserve to itself any or all of the authority or responsibility of the Administrator under the Plan or
may act as the Administrator of the Plan for any or all purposes. To the extent the Board has reserved any such authority or responsibility
or during any time that the Board is acting as Administrator of the Plan, the Board shall have all the powers of the Administrator hereunder,
and any reference in the Plan to the Administrator (other than in this Section 4(c)) shall include the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>5.&nbsp;Offerings</B>.
The Company will make one or more Offerings to Eligible Employees to purchase Common Stock under the 423 Component and may make one or
more Offerings to Eligible Employees and/or Consultants under the Non-423 Component. The Administrator shall, in its discretion, designate
the period of any Offering, provided that no Offering shall exceed 27 months in duration. Unless and until the Administrator determines
otherwise, each Offering shall be for a Purchase Period of 6 months beginning on the first day of a calendar quarter and ending on the
last day of the next succeeding calendar quarter. Subject to applicable law, the Administrator, or its delegate, retains the discretion
to impose trading restrictions or holding requirements on Common Stock purchased with respect to a particular Offering. If the Administrator
elects to impose such restrictions or requirements, the restrictions or requirements will be described in the enrollment materials for
the applicable Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>6.&nbsp;Eligibility</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;Except
as otherwise provided in this Section 6 (including, but not limited to, the provisions of Section 6(d) regarding the Non-423 Component),
all individuals classified as employees on the payroll records of the Company and each Designated Subsidiary shall be eligible to participate
in any one or more of the Offerings under the Plan (&ldquo;<U>Eligible Employees</U>&rdquo;). Notwithstanding the foregoing, no Participant
may be granted a Purchase Right under the 423 Component if such Participant, immediately after the Purchase Right was granted, would be
treated as owning stock possessing 5% or more of the total combined voting power or value of all classes of stock of the Company or any
Parent or Subsidiary. For purposes of the preceding sentence, the attribution rules of Section&nbsp;424(d) of the Code shall apply in
determining the stock ownership of a Participant, and all stock which the Participant has a contractual right to purchase shall be treated
as stock owned by the Participant. Further notwithstanding the foregoing, the Administrator may determine, prior to the beginning of an
Offering, that one or more of the following categories of Eligible Employees shall not be eligible to participate in the Plan with respect
to such Offering (provided that any such determination shall be applied in a consistent manner to all employees of the applicable corporation(s)):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 5; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(i)&nbsp;Employees
who have been employed by the Company or a Designated Subsidiary for fewer than two years (or such shorter period of time as may be specified
by the Administrator);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(ii) Employees
who customarily work not more than twenty (20) hours per week (or such shorter period of time as may be specified by the Administrator);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iii)&nbsp;Employees
who customarily work not more than five (5) months per calendar year (or such shorter period of time as may be specified by the Administrator);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(iv)&nbsp;&ldquo;Highly
compensated employees&rdquo; (as defined in Section 414(q) of the Code), or a subset of highly compensated employees specified by the
Administrator who (A) are officers of the Company and subject to the disclosure requirements of Section 16(a) of the Securities Exchange
Act of 1934 as amended, and/or (B) have compensation (within the meaning of Section 415(c)(3) of the Code) exceeding an amount specified
by the Administrator that is higher than the amount provided in Section 414(q)(1)(B)(i) of the Code for the applicable calendar year;
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(v) Employees
who are citizens or residents of a non-U.S. jurisdiction, if the grant of a purchase right under the Plan to such an employee would be
prohibited under the laws of such jurisdiction, or if compliance with the laws of such jurisdiction would cause the Plan to violate the
requirements of Section 423 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;Notwithstanding any other provision herein, individuals who are not classified as employees of the Company or a Designated Subsidiary
for purposes of the Company&rsquo;s or applicable Designated Subsidiary&rsquo;s payroll system on the Offering Date are not considered
to be &ldquo;Eligible Employees&rdquo; of the Company or any Designated Subsidiary and shall not be eligible to participate in the 423
Component with respect to such Offering. In the event any such individuals are reclassified as employees of the Company or a Designated
Subsidiary for any purpose, including, without limitation, common law or statutory employees, by any action of any third party, including,
without limitation, any government agency, or as a result of any private lawsuit, action or administrative proceeding, such individuals
shall, notwithstanding such reclassification, remain ineligible for participation in the 423 Component. Notwithstanding the foregoing,
the exclusive means for individuals who are not classified as of an Offering Date as employees of the Company or a Designated Subsidiary
on the Company&rsquo;s or Designated Subsidiary&rsquo;s payroll system to become eligible to participate in an Offering under the 423
Component is through an amendment to this Plan, duly executed by the Company, which specifically renders such individuals eligible to
participate herein. For purposes of the Plan, in accordance with Treas. Reg. &sect;&nbsp;1.421-1(h)(2),&nbsp;the employment relationship
shall be treated as continuing intact while the individual is on military leave, sick leave or other leave of absence approved by the
Company or a Designated Subsidiary that does not exceed three months and during any period longer than three months if the individual&rsquo;s
right to reemployment is guaranteed by statute or contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;The
Administrator retains the discretion to determine which Eligible Employees may participate in the 423 Component pursuant to and consistent
with Treasury Regulation &sect;&sect;&nbsp;1.423-2(e)&nbsp;and (f), and which Eligible Employees and Consultants may participate in the
Non-423 Component.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 6; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;Notwithstanding
anything in this Section&nbsp;6 to the contrary, in the case of an Offering under the Non-423 Component, (i) an Eligible Employee (or
group of Eligible Employees) may be excluded from, or included in, participation in the Non-423 Component or an Offering as the Administrator
may determine, in its sole discretion; and (ii) a Consultant (or group of Consultants) may be included in, or excluded from, participation
in the Non-423 Component or an Offering as the Administrator may determine, in its sole discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>7.&nbsp;Participation</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;<U>Participants
on Offering Date</U>. An Eligible Employee (or, with respect to the Non-423 Component, a Consultant) may elect to participate in the Plan
by properly completing and submitting an Enrollment Form (in the manner described in&nbsp;Section&nbsp;7(b)) by such deadline as shall
be established by the Administrator for the Offering and in accordance with enrollment procedures established by the Administrator. Participation
in the Plan is entirely voluntary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;<U>Enrollment</U>.
The Enrollment Form shall (i)&nbsp;state a whole percentage or, to the extent permitted by the Administrator, a fixed dollar amount, to
be deducted from an Eligible Employee&rsquo;s (or, with respect to the Non-423 Component, a Consultant&rsquo;s) Compensation per pay period
during an Offering, (ii)&nbsp;authorize the purchase of Common Stock in each Offering in accordance with the terms of the Plan and (iii)&nbsp;specify
the exact name or names in which shares of Common Stock purchased for such individual are to be issued pursuant to&nbsp;Section&nbsp;13.
An eligible individual who does not enroll in an Offering in accordance with these procedures shall be deemed to have waived participation
in such Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;<U>Automatic&nbsp;Re-Enrollment</U>.
Except as otherwise determined by the Administrator prior to an Offering Date, the deduction rate selected in the Enrollment Form shall
remain in effect for subsequent Offerings unless the Participant (i)&nbsp;submits a new Enrollment Form authorizing a new level of payroll
deductions in accordance with&nbsp;Section&nbsp;9, (ii) withdraws from the Plan in accordance with&nbsp;Section&nbsp;10, or (iii)&nbsp;terminates
employment or other service or otherwise becomes ineligible to participate in the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;(d)&nbsp;<U>Electronic
Submission of Enrollment Form</U>. The Administrator may specify that Enrollment Forms to be submitted to the Company pursuant to this
Section 7 or Section 10 below are to be submitted electronically via the Company&rsquo;s intranet or the internet site of a third party
or via email or any other means of electronic delivery specified by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) Notwithstanding
the foregoing, participation in the 423 Component shall neither be permitted nor denied contrary to the requirements of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>8.&nbsp;Participant
Contributions</B>. Subject to the annual dollar amount limitation set forth in Section 11(b), each Eligible Employee (or, with respect
to the Non-423 Component, each eligible Consultant) may, by submitting an Enrollment Form as described in&nbsp;Section&nbsp;7(b), authorize
payroll deductions, in whole percentages, at a minimum of 1% up to a maximum of 25% of such individual&rsquo;s Compensation (or such other
maximum percentage deduction as may be determined by the Administrator), or, to the extent permitted by the Administrator, in a fixed
dollar amount, such individual&rsquo;s Compensation (between such minimum and maximum dollar amount as specified by the Administrator
prior to the applicable Offering), to be deducted on a pro rata basis for each pay period during an Offering. Payroll deductions shall
commence on the first payroll date following the Offering Date and end on the last payroll date on or before the last day of the Offering.
Payroll deductions shall be made in accordance with the Eligible Employee&rsquo;s (or, with respect to the Non-423 Component, the Consultant&rsquo;s)
election; however, if the Eligible Employee (or, with respect to the Non-423 Component, the Consultant) elects to contribute in whole
percentages, due to rounding or other administrative reasons, the actual percentage contributed may be less than the elected percentage.
The Company shall maintain notional book accounts showing the amount of payroll deductions made by each Participant for each Purchase
Period, but the Company will not hold payroll deductions in a trust or in any segregated account, unless otherwise determined by the Administrator
or required by applicable law. No interest shall accrue or be paid on payroll deductions, except as may be required by applicable law.
If required under applicable law or if specifically provided in the Offering, in either case as and to the extent determined by the Administrator,
in addition to or instead of making contributions by payroll deduction, a Participant may make contributions through a payment by cash,
check, or wire transfer prior to an Exercise Date, in such manner as may be directed by the Administrator. Any reference to &ldquo;payroll
deductions&rdquo; in this&nbsp;Section&nbsp;8&nbsp;(or in any other section of the Plan) shall similarly cover contributions by other
means made pursuant to this&nbsp;Section&nbsp;8.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>9.&nbsp;Deduction Changes</B>.
Except as may be determined by the Administrator in advance of an Offering, a Participant may not increase or decrease his or her payroll
deduction during any Offering, but may increase or decrease his or her payroll deduction with respect to the next Offering (subject to
the limitations of&nbsp;Section&nbsp;10) by filing a new Enrollment Form by such deadline as shall be established by the Administrator
for the Offering. The Administrator may, in advance of any Offering, establish rules permitting a Participant to increase, decrease or
terminate his or her payroll deduction during an Offering.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>10.&nbsp;Withdrawal</B>.
A Participant may withdraw from participation in the Plan by submitting to the Company a revised Enrollment Form indicating his or her
election to withdraw (in accordance with such procedures as may be established by the Administrator). The Participant&rsquo;s withdrawal
shall be effective as of the next business day, or as soon as practicable thereafter. Following a Participant&rsquo;s withdrawal, the
Company shall promptly refund such individual&rsquo;s entire account balance under the Plan to him or her (after payment for any Common
Stock purchased before the effective date of withdrawal). Partial withdrawals are not permitted. Such an individual may not begin participation
again during the remainder of the Offering, but may enroll in a subsequent Offering in accordance with&nbsp;Section&nbsp;7.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>11.&nbsp;Grant of Purchase
Rights</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;On
each Offering Date, the Company shall grant to each Participant in the Plan the right<I>&nbsp;</I>to purchase (&ldquo;<U>Purchase Right</U>&rdquo;),
on the Exercise Date and at the Purchase Price hereinafter provided for, the lowest of (i)&nbsp;a number of shares of Common Stock determined
by dividing such Participant&rsquo;s accumulated payroll deductions on such Exercise Date by the Purchase Price (as defined herein); (ii)
920 shares of Common Stock; or (iii)&nbsp;such other lesser maximum number of shares as shall have been established by the Administrator
in advance of the Offering (in each case subject to adjustment pursuant to&nbsp;Section&nbsp;15&nbsp;or&nbsp;Section&nbsp;16); provided,
however, that such Purchase Right shall be subject to the limitations set forth below. Each Participant&rsquo;s Purchase Right shall be
exercisable only to the extent of such Participant&rsquo;s accumulated payroll deductions on the Exercise Date. The purchase price for
each share purchased under each Purchase Right shall be as determined by the Administrator in advance of the applicable Offering (the&nbsp;&ldquo;<U>Purchase
Price</U>&rdquo;),<I>&nbsp;</I>provided that in no event shall the Purchase Price be less than the lesser of 85% of the Fair Market Value
of the Common Stock on the Offering Date or 85% of the Fair Market Value of the Common Stock on the Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;Notwithstanding
the foregoing, no Participant may be granted a Purchase Right which permits the Participant&rsquo;s rights to purchase stock under the
423 Component, and any other employee stock purchase plan (described in Section&nbsp;423 of the Code) of the Company and its Parents and
Subsidiaries, to accrue at a rate which exceeds $25,000 of the fair market value of such stock (determined on the Offering Date) for each
calendar year in which the Purchase Right is outstanding at any time. The purpose of the limitation in the preceding sentence is to comply
with Section&nbsp;423(b)(8) of the Code and shall be applied taking Purchase Rights into account in the order in which they were granted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>12.&nbsp;Exercise of
Purchase Right and Purchase of Shares</B>. Each individual who continues to be a Participant in the Plan on the Exercise Date shall be
deemed to have exercised his or her Purchase Right on such date and shall acquire from the Company such number of whole shares (and/or
fractional shares, as determined by the Administrator) of Common Stock reserved for the purpose of the Plan as the Participant&rsquo;s
accumulated payroll deductions on such date shall purchase at the Purchase Price, subject to any other limitations contained in the Plan.
Unless otherwise determined by the Administrator in advance of an Offering, any amount remaining in a Participant&rsquo;s account after
the purchase of shares on an Exercise Date of an Offering solely by reason of any inability to purchase a fractional share shall be carried
forward to the next Offering; any other balance remaining in a Participant&rsquo;s account at the end of an Offering shall be refunded
to the Participant promptly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>13.&nbsp;Issuance of
Shares</B>. Shares of Common Stock may be issued under the Plan, and certificates (if any) representing shares of Common Stock purchased
under the Plan may be issued only in the name of the Participant, or, to the extent permitted by the Administrator in its discretion in
the name of the Participant and another person of legal age as joint tenants with rights of survivorship, or in the name of a broker authorized
by the Participant to be his, her or their, nominee for such purpose. Participants will not have any voting, dividend, or other rights
of a stockholder with respect to the shares of Common Stock until such shares have been delivered pursuant to this&nbsp;Section&nbsp;13.
All transactions under this Plan are subject to the Company&rsquo;s insider trading policy as may be in effect from time to time. This
includes any blackout period prohibition or requirement to obtain mandatory&nbsp;pre-clearance&nbsp;of transactions such as enrollment,
withdrawal, or trading. If the standard enrollment period is scheduled to occur during a blackout period, arrangements will be made to
allow for restricted insiders to update their elections during the preceding open trading window.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>14.&nbsp;Rights on
Termination or Transfer of Employment or Other Service</B>. If a Participant&rsquo;s employment or other service terminates for any reason,
or if the Participant&rsquo;s status changes such that the Participant is no longer an Eligible Employee (or, in the case of the Non-423
Component, an eligible Consultant), before the Exercise Date for any Purchase Period, no payroll deduction shall be taken from any Compensation
due and owing to the Participant and the balance in the Participant&rsquo;s notional account shall be paid&mdash;as if such Participant
had withdrawn from the Plan under&nbsp;Section&nbsp;10&mdash;to such Participant or, in the case of such Participant&rsquo;s death, (a)
to the participant&rsquo;s designated beneficiary, if any, to the extent that the Administrator, in its discretion, has permitted the
designation of a beneficiary, or (b)&nbsp;otherwise, to the Participant&rsquo;s estate. A Participant shall be deemed to have terminated
employment or other service, for this purpose, if the entity by which the Participant is employed or with which the Participant has a
service relationship, ceases to be a Designated Subsidiary, or if the Participant&rsquo;s employment or other service is transferred to
any entity other than the Company or a Designated Subsidiary. Unless otherwise determined by the Administrator, a Participant whose employment
transfers between, or whose employment or other service terminates with an immediate rehire (with no break in service) by, a Designated
Subsidiary or the Company shall not be treated as having terminated employment or other service for purposes of participating in the Plan
or an Offering; provided, however, that if a Participant transfers from an Offering under the 423 Component to an Offering under the&nbsp;Non-423&nbsp;Component,
the exercise of the Participant&rsquo;s Purchase Right shall be qualified under the 423 Component only to the extent that such exercise
complies with Section&nbsp;423 of the Code. If a Participant transfers from an Offering under the&nbsp;Non-423&nbsp;Component to an Offering
under the 423 Component, the exercise of the Participant&rsquo;s Purchase Right shall remain&nbsp;non-qualified&nbsp;under the&nbsp;Non-423&nbsp;Component.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>15.&nbsp;Adjustment
in Case of Changes Affecting Common Stock</B>. Subject to any required action by the stockholders of the Company, in the event of any
change in the Common Stock effected without receipt of consideration by the Company, whether through merger, consolidation, reorganization,
reincorporation, recapitalization, reclassification, stock dividend, stock split, reverse stock&nbsp;split,&nbsp;split-up,&nbsp;split-off,&nbsp;spin-off,&nbsp;combination&nbsp;of
shares, exchange of shares, or similar change in the capital structure of the Company, or in the event of payment of a dividend or distribution
to the stockholders of the Company in a form other than Common Stock (excepting normal cash dividends) that has a material effect on the
Fair Market Value of shares of Common Stock, appropriate adjustments shall be made in the number and class of shares subject to the Plan,
the limit on the shares which may be purchased by any Participant during an Offering (as described in Section 11(a)) and the number of
shares of Common Stock subject to, and the Purchase Price of, each outstanding Purchase Right, in order to prevent dilution or enlargement
of Participants&rsquo; rights under the Plan. Any fractional share resulting from an adjustment pursuant to this Section&nbsp;15 shall
be rounded down to the nearest whole number, and in no event may the Purchase Price of any Purchase Right be decreased to an amount less
than the par value, if any, of the stock subject to the Purchase Right. The adjustments determined by the Administrator pursuant to this
Section&nbsp;15 shall be final, binding and conclusive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>16.&nbsp;Reorganization
Events</B>. In connection with a Reorganization Event, the Administrator may take such actions with respect to outstanding Purchase Rights
as the Administrator deems appropriate, consistent with applicable law and the treatment of the 423 Component as an &ldquo;employee stock
purchase plan&rdquo; within the meaning of Section 423(b) of the Code, including, any one or more of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a) provide
that Purchase Rights shall be assumed, or substantially equivalent Purchase Rights shall be substituted, by the acquiring or succeeding
corporation (or an affiliate thereof);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b) upon
written notice to Participants, provide that all outstanding Purchase Rights will be terminated as of the effective date of the Reorganization
Event and that all such outstanding Purchase Rights will become exercisable to the extent of accumulated payroll deductions as of a date
specified by the Administrator in such notice, which date shall not be less than ten (10)&nbsp;days preceding the effective date of the
Reorganization Event;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c) upon
written notice to Participants, provide that all outstanding Purchase Rights will be cancelled as of a date prior to the effective date
of the Reorganization Event and that all accumulated payroll deductions will be returned to the Participant on such date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d) in
the event of a Reorganization Event under the terms of which holders of Common Stock will receive, upon consummation thereof, a cash payment
for each share surrendered in the Reorganization Event, make or provide for a cash payment to a Participant equal to the excess, if any,
of (1) the amount of cash payable for a Common Share pursuant to the Reorganization Event times the number of shares of Common Stock subject
to the Participant&rsquo;s Purchase Right over (2)&nbsp;the aggregate Purchase Price of the Common Stock subject to such Purchase Right,
in exchange for the termination of such Purchase Right;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e) provide
that, in connection with a liquidation or dissolution of the Company, Purchase Rights shall convert into the right to receive liquidation
proceeds (net of the Purchase Price thereof); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f) any
combination of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">For purposes of clause&nbsp;(a)
above, a Purchase Right shall be considered assumed if, following consummation of the Reorganization Event, the Purchase Right confers
the right to purchase, for each share of Common Stock subject to the Purchase Right immediately prior to the consummation of the Reorganization
Event, the consideration (whether cash, securities, or other property) received as a result of the Reorganization Event by holders of
Common Stock for each share of Common Stock held immediately prior to the consummation of the Reorganization Event (and if holders were
offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding shares of Common Stock);
provided, however, that if the consideration received as a result of the Reorganization Event is not solely common stock of the acquiring
or succeeding corporation (or an affiliate thereof), the Company may, with the consent of the acquiring or succeeding corporation, provide
for the consideration to be received upon the exercise of Purchase Rights to consist solely of common stock of the acquiring or succeeding
corporation (or an affiliate thereof) equivalent in value (as determined by the Administrator) to the per share consideration received
by holders of outstanding shares of Common Stock as a result of the Reorganization Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, with respect
to any outstanding Purchase Right under the 423 Component of the Plan, any action taken under this&nbsp;Section&nbsp;16&nbsp;shall be
consistent with the intent that such Purchase Rights comply with Section&nbsp;423 of the Code, unless otherwise expressly determined by
the Administrator. The Plan shall in no event be construed to restrict in any way the Company&rsquo;s right to undertake a dissolution,
liquidation, merger, consolidation or other Reorganization Event.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>17.&nbsp;Special Rules
and&nbsp;Sub-Plans</B>. Notwithstanding anything herein to the contrary, the Administrator may adopt special rules or&nbsp;sub-plans&nbsp;applicable
to Participants who are employees of or Consultants to a particular Designated Subsidiary, whenever the Administrator determines that
such rules are necessary or appropriate for the implementation of the Plan in a jurisdiction where such Designated Subsidiary has employees
or Consultants, regarding, without limitation, eligibility to participate in the Plan, handling and making of payroll deductions or contribution
by other means, establishment of bank or trust accounts to hold payroll deductions, payment of interest, conversion of local currency,
obligations to pay payroll tax, withholding procedures and handling of share issuances, any of which may vary according to applicable
requirements; provided that if such special rules or&nbsp;sub-plans&nbsp;are inconsistent with the requirements of Section&nbsp;423 of
the Code, any employees subject to such special rules or&nbsp;sub-plans&nbsp;shall participate in the&nbsp;Non-423&nbsp;Component, and
Purchase Rights granted thereunder will not be required by the terms of the Plan to comply with Section&nbsp;423 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>18.&nbsp;Amendment,
Suspension and Termination of the Plan</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;<U>Amendment
of the Plan</U>. The Board may at any time and from time to time amend the Plan in any respect, except that, without the approval by the
stockholders of the Company within 12 months of such Board action, no amendment shall be made increasing the number of shares approved
for the Plan or making any other change that would require stockholder approval under the requirements of any stock exchange upon which
the shares may then be listed or in order for the 423 Component of the Plan, as amended, to qualify as an &ldquo;employee stock purchase
plan&rdquo; under Section&nbsp;423(b) of the Code. In no event may any amendment be made which would cause the 423 Component of the Plan
to fail to comply with Section&nbsp;423 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;<U>Suspension
of the Plan</U>. The Administrator may, at any time, suspend the Plan; provided that the Company shall provide notice to the Participants
prior to the effectiveness of such suspension. The Administrator may resume the operation of the Plan following any such suspension; provided
that the Company shall provide notice to the Participants prior to the date of termination of the suspension period. A Participant shall
remain a Participant in the Plan during any suspension period (unless the Participant withdraws pursuant to&nbsp;Section&nbsp;10). However,
no Purchase Rights shall be granted or exercised, and no payroll deductions shall be made in respect of any Participant, during the suspension
period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;<U>Termination
of the Plan</U>. The Board reserves the right to terminate the Plan, in whole or in part, at any time. The Plan shall terminate upon the
date when all shares of Common Stock reserved under Section 3 of the Plan have been purchased, or upon such earlier date as may be determined
by the Board. Upon termination of the Plan, all amounts in the accounts of Participants shall be promptly refunded.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>19.&nbsp;Insufficient
Shares</B>. If the total number of shares of Common Stock that would otherwise be purchased on any Exercise Date plus the number of shares
of Common Stock purchased under previous Offerings under the Plan exceeds the maximum number of shares issuable under the Plan, the shares
then available shall be apportioned in a manner consistent with the requirements of Section&nbsp;423(b)(4) and (5)&nbsp;of the Code and
the regulations thereunder among Participants in proportion to the amount of payroll deductions accumulated on behalf of each Participant
that would otherwise be used to purchase Common Stock on such Exercise Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>20.&nbsp;Notification
Upon Sale of Shares Under 423 Component</B>. Each Participant shall agree, by enrolling in the 423 Component of the Plan, to give the
Company prompt notice of any disposition of shares purchased under the Plan where such disposition occurs within two years after the date
of grant of the Purchase Right pursuant to which such shares were purchased or within one year after the date such shares were purchased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>21.&nbsp;Equal Rights
and Privileges</B>. Notwithstanding any provision of the Plan to the contrary and in accordance with Section&nbsp;423 of the Code, all
Eligible Employees participating in the 423 Component shall have the same rights and privileges.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>22.&nbsp;General</B>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(a)&nbsp;<U>No Right to
Purchase Rights; No Stockholder Rights; No Right to Employment or other service</U>. No person shall have any right to be granted any
Purchase Right under the Plan. No person shall have any rights as a stockholder with respect to any Common Stock to be issued under the
Plan prior to the issuance thereof. The Plan is not a contract of employment or service, and the terms of employment or service of any
Participant shall not be affected in any way by the Plan except as specifically provided in the Plan. The establishment of, enrollment
in, or grant of a Purchase Right under the Plan shall not be construed as giving any person the right to be retained in the employ or
other service of the Company or any Subsidiary. Further, the Company and each Subsidiary expressly reserves the right at any time to dismiss
an employee or Consultant, free from any liability or any claim under the Plan, except as expressly provided herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(b)&nbsp;<U>Purchase Rights
Not Transferable</U>. Except as provided herein, or to the extent otherwise required by applicable law, no Participant may alienate, commute,
anticipate, assign, pledge, encumber, transfer, or dispose of any Purchase Rights hereunder, which Purchase Rights and the right to receive
them are expressly declared to be nonassignable and nontransferable. Further, notwithstanding any other provision of the Plan to the contrary,
Purchase Rights under the 423 Component are not transferable by a Participant other than by will or the laws of descent and distribution
and are exercisable during the Participant&rsquo;s lifetime only by the Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(c)&nbsp;<U>Application
of Funds</U>. All funds received or held by the Company under the Plan may be combined with other corporate funds and may be used for
any corporate purpose, unless otherwise required under applicable law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(d)&nbsp;<U>Governmental
Regulations</U>. The Company&rsquo;s obligation to sell and deliver Common Stock under the Plan is subject to the completion of any registration
or qualification of the Common Stock under any U.S. or&nbsp;non-U.S.&nbsp;local, state or federal securities or exchange control law,
or under rulings or regulations of the SEC or of any other governmental regulatory body, and to obtaining any approval or other clearance
from any U.S. and&nbsp;non-U.S.&nbsp;local, state or federal governmental agency, which registration, qualification or approval the Company
may, in its absolute discretion, deem necessary or advisable. The Company is under no obligation to register or qualify the Common Stock
with the SEC or any other U.S. or&nbsp;non-U.S.&nbsp;securities commission or to seek approval or clearance from any governmental authority
for the issuance or sale of such stock. If, pursuant to this&nbsp;Section&nbsp;22, the Administrator determines that the shares of Common
Stock will not be issued to any Participant, all accumulated payroll deductions will be promptly refunded, without interest (unless otherwise
required pursuant to applicable law), to the Participant, without any liability to the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(e)&nbsp;<U>Successors and
Assigns</U>. The Plan shall be binding on the Company and its successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(f)&nbsp;<U>Entire Plan</U>.
This Plan constitutes the entire plan with respect to the subject matter hereof and supersedes all prior plans with respect to the subject
matter hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(g)&nbsp;<U>Compliance with
Applicable Law</U>. The obligations of the Company with respect to payments under the Plan are subject to compliance with all applicable
laws and regulations. Common Stock shall not be issued with respect to a right to purchase unless the issuance and delivery of the shares
of Common Stock pursuant thereto shall comply with all applicable provisions of law, including, without limitation, the Securities Act
of 1933 and the Securities Exchange Act of 1934 (each as amended) and the requirements of any stock exchange upon which the shares may
then be listed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(h)&nbsp;<U>Severability
of Provisions</U>. If any provision of the Plan shall be held invalid or unenforceable, such invalidity or unenforceability shall not
affect any other provision hereof, and the Plan shall be construed and enforced as if such provision had not been included.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;<U>Governing Law</U>.
This Plan and all Purchase Rights and actions taken thereunder shall be governed by, and construed in accordance with, applicable federal
law and, to the extent not preempted by applicable federal law, the laws of the State of Delaware, applied without regard to conflict
of law principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(j)&nbsp;<U>Tax Withholding</U>.
Participation in the Plan is subject to any applicable U.S. and&nbsp;non-U.S.&nbsp;federal, state or local tax withholding requirements
on income the Participant realizes in connection with the Plan. Each Participant agrees, by entering the Plan, that the Company or any
Subsidiary may, but shall not be obligated to, withhold from a Participant&rsquo;s wages, salary or other compensation at any time the
amount necessary for the Company or any Subsidiary to meet applicable withholding obligations, including any withholding required to make
available to the Company or any Subsidiary any tax deductions or benefits attributable to the sale or disposition of Common Stock by such
Participant. In addition, the Company or any Subsidiary may, but shall not be obligated to, withhold from the proceeds of the sale of
Common Stock or any other method of withholding that the Company or any Subsidiary deems appropriate to the extent permitted by U.S. Treasury
Regulation&nbsp;Section&nbsp;1.423-2(f)&nbsp;with respect to the 423 Component. The Company shall not be required to issue any Common
Stock under the Plan until any such obligations are satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(k)&nbsp;<U>Section&nbsp;409A
of the Code</U>. The 423 Component of the Plan is intended to be exempt from the provisions of Section&nbsp;409A of the Code, and any
ambiguities herein shall be interpreted to so be exempt from Section&nbsp;409A of the Code. The&nbsp;Non-423&nbsp;Component is intended
to be exempt from, or to comply with, the provisions of Section&nbsp;409A of the Code, any ambiguities herein shall be interpreted in
accordance with such intent. Notwithstanding the foregoing, neither the Company, the Board, the Committee nor the Administrator shall
have any liability to a Participant or any other party if a Purchase Right to purchase Common Stock under the Plan that is intended to
be exempt from or compliant with Section&nbsp;409A of the Code is not so exempt or compliant, or for any action taken by the Administrator
with respect thereto. The Company makes no guaranty or warranty of the tax treatment of Purchase Rights under the Plan, under Section
409A or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(l)&nbsp;<U>Incapacity</U>.
Any benefit payable to or for the benefit of a minor, an incompetent person, or other person incapable of accepting receipt shall be deemed
paid when paid to such person&rsquo;s guardian, agent or attorney-in-fact under a power of attorney, or to the party providing or reasonably
appearing to provide for the care of such person, and such payment shall fully discharge any liability or obligation of the Board, the
Administrator, the Company and any Designated Subsidiary, and all other parties with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(m)&nbsp;<U>Headings and
Captions; Rules of Construction</U>. The headings and captions herein are provided for reference and convenience only, shall not be considered
part of the Plan, and shall not be employed in the construction of the Plan. Whenever used in the Plan, words in the masculine gender
shall be deemed to refer to females as well as to males; words in the singular shall be deemed to refer also to the plural; and references
to a statute or statutory provision shall be construed as if they referred also to that provision (or to a successor provision of similar
import) as currently in effect, as amended, or as reenacted, and to any regulations and other formal guidance of general applicability
issued thereunder. Except where otherwise indicated, references to Sections are references to sections of this Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(n)&nbsp;<U>Unfunded Status
of Plan</U>. The Plan is unfunded and shall not create or be construed to create a trust or separate fund of any kind or a fiduciary relationship
between any Participant (or beneficiary thereof), on the one hand, and the Company, any Designated Subsidiary, the Board, the Administrator,
or any other person, on the other hand.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[END OF DOCUMENT]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 15; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>ameh-20230613.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +aA5w7xRiXgen8uLa3ZcWaiKCbOdzZR+CYkxtmB2bcnKXyst1JF4ziJ3az82IZcC -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:AMEH="http://apollomed.net/20230613" elementFormDefault="qualified" targetNamespace="http://apollomed.net/20230613">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://apollomed.net/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="ameh-20230613_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="ameh-20230613_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
    <import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>ameh-20230613_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>ameh-20230613_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.18b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://apollomed.net/role/Cover" xlink:href="ameh-20230613.xsd#Cover" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://apollomed.net/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>6
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140150415738672">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jun. 13, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jun. 13,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-37392<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">APOLLO MEDICAL HOLDINGS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001083446<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">95-4472349<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1668 S. Garfield Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">2nd Floor<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Alhambra<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">91801<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">626<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">282-0288<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMEH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>tm2318926d1_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ameh-20230613.xsd" xlink:type="simple"/>
    <context id="From2023-06-13to2023-06-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001083446</identifier>
        </entity>
        <period>
            <startDate>2023-06-13</startDate>
            <endDate>2023-06-13</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2023-06-13to2023-06-13">0001083446</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2023-06-13to2023-06-13">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2023-06-13to2023-06-13">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2023-06-13to2023-06-13">2023-06-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2023-06-13to2023-06-13">APOLLO MEDICAL HOLDINGS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2023-06-13to2023-06-13">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2023-06-13to2023-06-13">001-37392</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2023-06-13to2023-06-13">95-4472349</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2023-06-13to2023-06-13">1668 S. Garfield Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2023-06-13to2023-06-13">2nd Floor</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2023-06-13to2023-06-13">Alhambra</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2023-06-13to2023-06-13">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="From2023-06-13to2023-06-13">91801</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2023-06-13to2023-06-13">626</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2023-06-13to2023-06-13">282-0288</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2023-06-13to2023-06-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2023-06-13to2023-06-13">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2023-06-13to2023-06-13">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2023-06-13to2023-06-13">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="From2023-06-13to2023-06-13">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2023-06-13to2023-06-13">AMEH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2023-06-13to2023-06-13">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2023-06-13to2023-06-13">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MY?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^
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M$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @ #8305@=!36*!    L0
M !               ( !     &1O8U!R;W!S+V%P<"YX;6Q02P$"% ,4
M"  -A-!6-[XT)>X    K @  $0              @ &O    9&]C4')O<',O
M8V]R92YX;6Q02P$"% ,4    "  -A-!6F5R<(Q &  "<)P  $P
M    @ ', 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0    (  V$T%9X
M?_0T6 0   X1   8              " @0T(  !X;"]W;W)K<VAE971S+W-H
M965T,2YX;6Q02P$"% ,4    "  -A-!6GZ ;\+$"  #B#   #0
M    @ &;#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    (  V$T%:7BKL<P
M !,"   +              "  7</  !?<F5L<R\N<F5L<U!+ 0(4 Q0    (
M  V$T%:JQ"(6,P$  "("   /              "  6 0  !X;"]W;W)K8F]O
M:RYX;6Q02P$"% ,4    "  -A-!6)!Z;HJT   #X 0  &@
M@ ' $0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4    "  -
MA-!699!YDAD!  #/ P  $P              @ &E$@  6T-O;G1E;G1?5'EP
=97-=+GAM;%!+!08     "0 ) #X"  #O$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="tm2318926d1_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://apollomed.net/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tm2318926d1_8k.htm">tm2318926d1_8k.htm</File>
    <File>ameh-20230613.xsd</File>
    <File>ameh-20230613_lab.xml</File>
    <File>ameh-20230613_pre.xml</File>
    <File>tm2318926d1_ex10-1.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tm2318926d1_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2021q4": 23
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "tm2318926d1_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ameh-20230613_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ameh-20230613_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ameh-20230613.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 59,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021q4": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 23,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "AMEH",
   "nsuri": "http://apollomed.net/20230613",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2318926d1_8k.htm",
      "contextRef": "From2023-06-13to2023-06-13",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://apollomed.net/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "tm2318926d1_8k.htm",
      "contextRef": "From2023-06-13to2023-06-13",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r15"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r19"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r16"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r14"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r9"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://apollomed.net/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 3
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r10": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r11": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r12": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r13": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r14": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r15": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r16": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r17": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r18": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r19": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r7": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r8": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r9": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001104659-23-072288-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001104659-23-072288-xbrl.zip
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MK/Q [#_ $YJC^A=BVT26MT8KR#7-\@]02P,$%     @ #8305CT7:RG_"@
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MF:01IH6?2[DM[2BB1>L:$M"N"4I+&!0LD#L0F") <Y.'>(?F7P2+8<C4E'Z
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M!G@70UUBL"ZW9,"_=#,7RJ&F.>%CEIE#1;*!Z]S\*%S-A7*0U03SP+8,,%4
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M*BSEI\0&Q44&PX9\>&N;H*I01^I'!ALPP=.H'LL+[$D](1+Y&XB.\5H3?K^
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M[R-8P<"Z_3&L#6OV[L_+/9VVR]^Z@\^UY@_M=^_+?OW3)XF*_P-02P,$%
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MVQ;X$/O^0R]Y2E+Q34\J6F-M/++6VIYT1K!2.IN1"+!_=DKS6O;GM6K =^&
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ML)"J-F=C9EE3I*2^P[E8Y[_4#4%R9-KLL\>C=WRXJ[_$H O<D$IF3>O7 /X
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M(VPWM)?00L#M'7;R#%JK)&"Q>;8JWL*W2WA>WDC$?T:>, %$L9^=9;[^]S;
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M0P576HOCC7I3,0M+UGPU?OA3!_1P1()P,QC]#;8.N#'(18;8W:*13B$K$SK
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M'S*S,S^O1,=A8Y/[9SGA8YR81OCFR?E].6[_D/ P$I73.;OLG0T;0>8 <C)
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MW;Y7U':'(DI]G(>GBLK?@""5:MU=@(['&EIV$ 7CV[>8;?]-:ZQ;!R@QD0Y
M;*UU-P0$QWZR7N;MS>.\3?6.&(]N\J5+C%=1L1ZI]R2X1VYJ>?3TP!-+,9@N
M69J\NYF!JSMU7L,F>9ECNIJ;RH#)6S"A")F\L?7I]E"_HB%N H5M&;RQ2L$Z
M^RQ+I!<^$7-S\[CUZRRQ?O[L4('X618"7(9J>-UI6NZM<YR)$P\GP[,(KL1%
MZ]!Y!.,UW8FB:%73:;$E]_2L&(_L0=>$:#/00'FK0BQ)+C++23HX-7O$"@;H
M1'8U-#_$-V/?3G6!T^&485HTUXKKZ)!!#->[N\%8B1\R=D[A\6'/+2IU87AT
M=-U>B4FSCY 3V\ %9OD&(T7$-XSRA90I0:GYUXBJFPUS2TIH)TS["U^FHJZ#
MO49BQ^VVO0..2445#L:R_UC2C9!81J5WLS"[6ZQB>)V;3$MOD.8F5 6!4=6U
MNVQO+W!+$^";2@_MSJ'LZJ];4,]4I338'KR?,_8I;?MH9N8N"[L+]@7W^ZKY
MJ/G:-Q'1[.DX0*+DYG?/%X>8^-G(FNPFCS\Z:JBGYGR 86>[-UXZH 4!-9Y:
M(@TQF2Y=/W?M]/<*.=DFD\H6H6H5D:?""C%/J=/BG+3G\"06@N"S[7=!L('=
M=NFRA\XKNI3%AGYKR8%S_73%$&I$HG,%RMHTUR@K\%?H!SD&V+JYSJOB-_X;
MF1**2G7CP2L6^:;H8)Y_\Y]$/+*<J_(!%_Z[A;/8X>4@I&P2SQ*,X#?JW_>V
MF^#/>K5R?X-/X__D!EFY/]<8^K,Q?".,]#YL3/I#JD^R<)[EK6!8#9B9V\;T
M%LL'M=QZ620EF3'V?0D6CDI.*EJ<X;5G*T@Q*,)FE>8-UG["M5:X%RNX#KN#
M@8'HGMI.601R'RS;S] &>FS?R20>(QW9FC$YZJ8IN">S/2>)\D<*]'&.A:*F
MN!W4C:-X%857%<C=9HGD:C:5)%2EP*A,P*PE=!_O+8"P?D87*Z;SZ=39_"XC
M9'=++Z[G!SUSOXK -/5*RJ=U\C04TG3$.2F)R8:&=\ZR*+?6?S05[$4..U$@
M4D<S1?+;,&L82.8RKE[2@GFD<216;:6Q9%F?4/#\D6+4HB).HDJZJWR^(Z<B
M0<ZB\1S.+).6 Q_ATB5G*W3Q6(F1@<Y0_Z5H3%L##\8D[I+<]BZ4KG?>*:E7
M_ECU-EGP&$YCZSU\D'9FB"TCG"KJ& L"J 3GMK"\],21(%S7IZ9:CXCKG=__
MH -[Y_<_1O;>]UT*!J#M;/M38/&,1U<HPR1O^+S"DUP95<259^$/,KI^J/TC
M!J@DKR'Y@#BS-*PZ6NI.V;\OQC-:K9MGNL<B#S*LJK;JB]Q3:Z_TG2HJH+:E
MP"%H:CP*4%.V*/A RQY"^&@O*VC$,- IUO$Z_+E-'__Z4@/KR9/.ZWIH)X4]
M;K=KPVE,+'#!V&I!I?+H@-PBZ&O/K^D7!9+%+V=6\S%X1@@;?!-R])^=X4_$
M*:B<5UAP*)DN\!96?V!;L/<94F6!D-EV@U+BKL& )C-+< F]MMM<4WLVR7'J
M]YQSEVQ4P2)?A]:OO,)/DU)+#KH\D<L:#C^6FU@H0'X/BW\ EB0-.FA\8$[O
MI9AQE 4\<;9SA4(T22A-H=1AFB?G]R4DO,QWK<JD#L[0>)22TZ>T5Q?_UKVZ
MP)1)6?K^+#SY 8%0N#"NAB"U,.'6/;#A[!@: WYZY9GN@AR)PLJ=TJHOIP[J
MXZ-*Z2GW[J1C@.73J$(4@4M,\TX1)^RO@IN++(_M>LVW%8V P7,*34ATA.O(
M5:E-NVVX.XU''::-*F)0J5VI&J<)@WLS%YA>>(,!4"_#%B!'G,=(6W!R/F6M
MYQA_[ USV_$H=^]M2X.4+SBP@3M:SB"V, 09$E<U!>,;BO423<KDPG)UXO"O
MA1DHX6?WXH;*.4Y4?3$+CHN66?2J[NWM4HS!#T_I8)G(0*/(3M\[* NPI98.
M'; L6O!&MYH(Q\43TS8:W!+6NF-T.UZO6@#1R=./H!Z&7$@PJ8RSZZ,=X2RU
M[ ]L1/G^K]AJ*O%T'R/V3H;4K)Q4/4#<V&M18EM*H6]"@$ ^KU&R]PIU/!#:
M-2"T;@B(UIGBX@OTP1Y]/TL$Z?#'F&]C[>6VO?4\9UFD1H8CMJF;NP0P<8HI
M*^7PD,6\GKG+?9IE8O,J1.*%G%?2#E>A3+E'0D? 83K!R[CCWZ!2 1/:*V/"
MV/C7/3 ;-Z9<_BLO+2.84'1WY8:!Q32H1E>\";+%32U*)Y@8GJMNM^E_A3]I
MC<M0*6,#TQ:_U W!#WA(VA)-*]/I8Y*!0RGP_HJ]\QH4S"8OU032*I)CSK:P
MU_K/E)WW#G1VE/\<T@@0G8[CD,2AJWC-@*.>!0DZIZ6L'@_?G_$D;A;(BHL3
MT+%F8O)'##'9::!%W3,3ORN2H ,8H%RY_FUR3"6.138AI().0WK-"7&N-MSA
M[77L+OD8YN^'^<\_[##_^<<P_WN^2Y][:L\$'S;%GP<C'</0(]T05;4$9BRJ
M+]=(TG$(AL$50,:!>[PS4K$&>*98&G--[6%,4X(IUKS%RJ6VW(4BE2VNB"3T
MM<6H\G!UAE<LP:[9<O#%ED18 M"[/$"?A*7<5"R!TT3)D5R[2."(*N=FE@:I
M>,/JHR"F3);MF/8*(Z]YF?V$-'L(YA0(V*OM_!XNI"2U$GW4N<D@$^CTFPJF
M4UOYLD89+,]D:C]+0@.6^#W,$\DA\.DH.GAAO98T?0YZ.<,C=%-3BO$P)'*+
MP)T!*"R8XA5:?\F<F>QVBBG#^><&V#1HXBDS&"<2>*>&O5@;JL#N9AAP"BQF
MUV\%%JDIVF4AH0"<23Z[Z0["-[IY-1F-ZG41(76=-\/=RAE;[RM8'58TZ+:"
MT.MJ65I$@C 9I_FMZY""E\PDU7]#<3C:[.$\K]YP/1;R53M&;019I^FM9QHK
M9=FF9Q+ML*U0RGJ!L"8*#RXH7 </O99*97I53[W<Y6]Y>O"!5.:FF +AA=W;
MVS@<55QBU+J5W.-*08UN<5F8%TZJ!?2FU2TN/.+6.1E<_'?426BHP61"ZL==
M-!*"G:4T2W9":KLC$X?WCAJ+%)#W=L]><"^37,0:R3)\D"'/*M#584:<X$&X
MV9TAQQ1Q!%+W] 2\[2QR:7O#SQ"1WF*M"W6I@-W^.HS5VHD]7<H^;$AFI\ME
MGGA*;'^E;VHL'"5=Y@E/:#9[9;%9CO<*93Y!?LF<=#3X'!>V,IL<8NHOCYT'
MI+_\/@RHP"G.+VQC>!MUYY'FPC0/9EAN7ZV'Q20HG<V,]OGKI-V]#PXP34=C
M]8.G,)!D ,FXNWH+0EV.<5 H[=[/F\NQ)*,J"48OVPP#!1U(^+),D]$)<+"B
M_"\*R*5@;AE :8>\SQYO>6HP%@1+QUCXW3YDBPLOCD<:V<*ODR"LB8H&(M@C
M,UW8M;&KPFJ&)W&!(=?]KT%&T@I;8;VW8O&O1F&X,^[%X, A3Y!5J]..!"EX
M W^T8_6NSZ<CZ*5DI$^G1SF\-NJCX]+@Q"3L^)S<R(>ZO6'4:<U[!0/(?<O3
MA]T=TXV_JW\1 13]GC<)@\8.7M%7-OZY4D^?+,=SC1>'&8,4\7KOGMEDH!NC
M;X5X@"SS_O0L^TYBQ.,1TI4-X:2L24,=P(66B*'.J9+4!";>8OPL[%GS>2A2
M@%9M8)FY$SK)JGVHLF#VZFLA66K#W*AGB/?*P+448R6"ENZLSVVF0AS^)C8J
M/AXMF;(-E!)AJM)!8D?\%*B-[$%P6CTMB"MJH"01/8L+U_*F++ ?-A5<)/HA
M.,84FHJS[&<:9MKTFS&29LV.F1PQYZA%A0:JGCFD'S\5QK2C>3C/+S[LJ/;%
MQZCV^[E#E3]H.ZH\K]KM"@OGR<?1A%?"CM/56-%V$(^D;'S=VE<57]7L[X2D
M#9MRFP8\D?P>: #.$A(+H8H:?JX;+0<L698?$S\8I..FB Z"MF+N+N]4D(,!
MH[\%>YHNU>R2=8-2DU%HF'RF+EJ_)SJ#3)8/N;IL\LB2%X2TEH)J,-?;T@:T
M?+0$Q#1F(+1$1HW5U#)$UY)Q7Y<ZC9K$"E #;[K":V,N>C$($RN^E2HLA_:/
M:9K[S.RG$E[PY^_"MECYL>Y<T>MX1,KX55XJ"LWL9UK=P--3M)I]NHK\NC&&
M</G,9Z6J__=XO;!@UP@,ZW0W$5;DUK87*W19M)NZ+1RDCT<9GTYW"%4@._@E
M,FFUKOKCKB:&V989&YVG0%+@VC:32"!R-*R2763-HD:LK4H"-?9Y6#-"C+;A
MX_;\^ 2WJ&WF<45H6%=/A$2O37%;E,;VWTJE@]@Q;&-W,TH,V;K/N&W/_I0D
M>8$]>J$VS7B1:D_-)"XHWY%94"IC<2@;]V(GN-Z6YO?O!E28M'PZD5GHQ7W!
MDOU)_,)>JN(Q-CM]I0*8ZF/[HXC&*V!J86\4+A:.3+4G*2!L;Z%ISQ&#.@@N
MX$KN_3=L&86TCZ#2MW&R-EV=HC:%@>!)#J(Z-BUF85C*+1;H6RYGGJ,9(8^-
MHTMR188VN9.\SI%<]'6?)(MR2W&AL 26)]0:AAO=S#K=)I;G%=\DSEW.%%<D
M M_)"7=ZJH=]C51B,%8/@H#A@ IV\I/7,HA0<+U*0+7,,T0=[D(ZH"@O(.1H
MFFOIVVV#OPBQ@]3V&@T+E6KVB(]$X$3G/6"(H./714MZPI/F!\GI6;9JC/&,
M:V5AJ91EC(LR+]8]<]ROF1^.6S"&'9Q0F$''KWLEOZ".':4@^BLL<'R/S&C:
MF!0U+-AS!OUP+^9DJP88N:FDGGB]WL(_<"?8[# F5Q#+, ._SRRO#1ZCA3!
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M96@M,C R,S V,3,N>'-D4$L! A0#%     @ #8305CT7:RG_"@  ;(<  !4
M             ( !;@,  &%M96@M,C R,S V,3-?;&%B+GAM;%!+ 0(4 Q0
M   (  V$T%;2%QHN5@<  ,-8   5              "  : .  !A;65H+3(P
M,C,P-C$S7W!R92YX;6Q02P$"% ,4    "  -A-!6VV[[$\0?  #NQ   $@
M            @ $I%@  =&TR,S$X.3(V9#%?.&LN:'1M4$L! A0#%     @
M#8305FB79'<8/P  C5$! !8              ( !'38  '1M,C,Q.#DR-F0Q
A7V5X,3 M,2YH=&U02P4&      4 !0!) 0  :74

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
